SCHEMBL17632929

SCHEMBL17632929

C=C[C@]1(CO)O[C@@H](n2cnc3c(N)ncnc32)[C@H](O)[C@@H]1O

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PRMT5 O14744 1/20 0.58
▸ WDR77 Q9BQA1 1/20 0.58
▸ ADORA3 P0DMS8 3/20 0.56
▸ DPP4 P27487 1/20 0.56
▸ MEN1 O00255 1/20 0.56
▸ SLC28A1 O00337 1/20 0.56
▸ MAP3K7 O43318 1/20 0.56
▸ SLC28A2 O43868 1/20 0.56
▸ GAPDH P04406 1/20 0.56
▸ MAPK1 P28482 1/20 0.56
▸ ADORA2A P29274 1/20 0.56
▸ ADORA2B P29275 1/20 0.56
▸ ADORA1 P30542 1/20 0.56
▸ STAT6 P42226 1/20 0.56
▸ PI4KA P42356 1/20 0.56
▸ KMT2A Q03164 1/20 0.56
▸ SMN1; SMN2 Q16637 1/20 0.56
▸ PI4K2B Q8TCG2 1/20 0.56
▸ DOT1L Q8TEK3 1/20 0.56
▸ SLC29A1 Q99808 1/20 0.56

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29987989 0.91 PRMT5 (0.56) PRMT5WDR77ADORA3DPP4MEN1
SCHEMBL15203726 0.89 ADORA3 (0.51) PRMT5WDR77ADORA3DPP4MEN1
SCHEMBL3831030 0.89 AHCY (0.58) PRMT5WDR77ADORA3DPP4MEN1
SCHEMBL12170660 0.87 AHCY (0.49) ADORA3DPP4MEN1SLC28A1MAP3K7
SCHEMBL18948229 0.87 AHCY (0.49) ADORA3DPP4MEN1SLC28A1MAP3K7
SCHEMBL12060715 0.87 PRMT5 (0.56) PRMT5WDR77ADORA3DPP4MEN1
SCHEMBL12386685 0.85 PRMT5 (0.56) PRMT5WDR77ADORA3DPP4MEN1
SCHEMBL18073288 0.85 PRMT5 (0.56) PRMT5WDR77ADORA3DPP4MEN1
SCHEMBL561654 0.82 PRMT5 (0.64) PRMT5WDR77ADORA3DPP4MEN1
SCHEMBL561515 0.82 PRMT5 (0.64) PRMT5WDR77ADORA3DPP4MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3197457-B1 4'-VINYL SUBSTITUTED NUCLEOSIDE DERIVATIVES AS INHIBITORS OF RESPIRATORY SYNCYTIAL VIRUS RNA REPLICATION RIBOSCIENCE LLC (US) 2022-11-09 — — EP claimed
EP-3197457-B1 4'-VINYL SUBSTITUTED NUCLEOSIDE DERIVATIVES AS INHIBITORS OF RESPIRATORY SYNCYTIAL VIRUS RNA REPLICATION RIBOSCIENCE LLC (US) 2022-11-09 — — EP disclosed
US-10358458-B2 4′-vinyl substituted nucleoside derivatives as inhibitors of respiratory syncytial virus RNA replication RIBOSCIENCE LLC (US) 2019-07-23 — — US disclosed
US-10358458-B2 4′-vinyl substituted nucleoside derivatives as inhibitors of respiratory syncytial virus RNA replication RIBOSCIENCE LLC (US) 2019-07-23 — — US disclosed
EP-3197457-A1 4'-VINYL SUBSTITUTED NUCLEOSIDE DERIVATIVES AS INHIBITORS OF RESPIRATORY SYNCYTIAL VIRUS RNA REPLICATION Riboscience LLC (US) 2017-08-02 — — EP disclosed
US-20160264611-A1 4'-VINYL SUBSTITUTED NUCLEOSIDE DERIVATIVES AS INHIBITORS OF RESPIRATORY SYNCYTIAL VIRUS RNA REPLICATION RIBOSCIENCE LLC 2016-09-15 — — US disclosed
US-20160264611-A1 4'-VINYL SUBSTITUTED NUCLEOSIDE DERIVATIVES AS INHIBITORS OF RESPIRATORY SYNCYTIAL VIRUS RNA REPLICATION RIBOSCIENCE LLC 2016-09-15 — — US disclosed
US-20160264611-A1 4'-VINYL SUBSTITUTED NUCLEOSIDE DERIVATIVES AS INHIBITORS OF RESPIRATORY SYNCYTIAL VIRUS RNA REPLICATION RIBOSCIENCE LLC 2016-09-15 — — US disclosed
WO-2016049415-A1 4'-VINYL SUBSTITUTED NUCLEOSIDE DERIVATIVES AS INHIBITORS OF RESPIRATORY SYNCYTIAL VIRUS RNA REPLICATION RIBOSCIENCE LLC (US) 2016-03-31 — — WO disclosed
WO-2016049415-A1 4'-VINYL SUBSTITUTED NUCLEOSIDE DERIVATIVES AS INHIBITORS OF RESPIRATORY SYNCYTIAL VIRUS RNA REPLICATION RIBOSCIENCE LLC (US) 2016-03-31 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160264611-A1 4'-VINYL SUBSTITUTED NUCLEOSIDE DERIVATIVES AS INHIBITORS OF RESPIRATORY SYNCYTIAL VIRUS RNA REPLICATION NSUN2, RNMT, RRM2 PRMT5 366/4885WDR77 1357/4885ADORA3 739/4885
US-10358458-B2 4′-vinyl substituted nucleoside derivatives as inhibitors of respiratory syncytial virus RNA replication NSUN2, RNMT, SNRPF PRMT5 347/4885WDR77 1421/4885ADORA3 733/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback